Literature DB >> 8360707

Responses of human glioblastoma cells to human natural tumor necrosis factor-alpha: susceptibility, mechanism of resistance and cytokine production studies.

S Sakuma1, Y Sawamura, M Tada, T Aida, H Abe, K Suzuki, N Taniguchi.   

Abstract

Responses and susceptibility of 14 human glioblastoma cell lines to human natural tumor necrosis factor-alpha (TNF) were studied in vitro. Susceptibility of glioblastoma cells to TNF varied in experimental conditions applied. Most of glioblastoma cell lines were resistant to cytotoxic activity of TNF in a MTT assay at concentrations below 16 U/ml for 72 h exposure. However, TNF at higher dose, in prolonged exposure and against low density of target cells was antiproliferative for certain glioblastoma cultures. TNF exposure at 10 U/ml for 48 h suppressed DNA synthesis in 9 of 14 glioblastoma cultures, but increased in 3 cultures. In addition, colony forming assay showed anti-clonogenic activity of TNF in 5 of 6 glioblastoma cell lines tested. In spite of their low susceptibility to TNF, glioblastoma cells well responded to TNF stimulation at low dose (10 U/ml) for a short period in the absence of cell damage. Productions of Interleukin-6 (IL-6), IL-8-like activity, granulocyte-macrophage colony stimulating factor (GM-CSF), prostaglandin E2 (PGE2) and manganous superoxide dismutase (Mn-SOD) were enhanced or induced by the low-dose TNF stimulation. Mn-SOD, a protein protective against oxidative cell damage, was well induced in time- and dose-dependent manner, however did not correlate with TNF resistance. Whereas the levels of PGE2 in TNF-susceptible cell lines, H-4 and SF-188, were higher than those of other lines. In conclusion, most of glioblastoma cells are resistant to TNF cytotoxic effects, but highly responsive to TNF stimulation. Its effect on glioblastoma cells appears to modulate cell differentiation rather than to kill the cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8360707     DOI: 10.1007/bf01050066

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  28 in total

1.  Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor.

Authors:  K W Selmaj; M Farooq; W T Norton; C S Raine; C F Brosnan
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

2.  Detection of cytokine mRNA in astrocyte cultures using the polymerase chain reaction.

Authors:  S L Wesselingh; N M Gough; J J Finlay-Jones; P J McDonald
Journal:  Lymphokine Res       Date:  1990

3.  Serum-manganese-superoxide dismutase: normal values and increased levels in patients with acute myocardial infarction and several malignant diseases determined by an enzyme-linked immunosorbent assay using a monoclonal antibody.

Authors:  T Kawaguchi; K Suzuki; Y Matsuda; T Nishiura; T Uda; M Ono; C Sekiya; M Ishikawa; S Iino; Y Endo
Journal:  J Immunol Methods       Date:  1990-03-09       Impact factor: 2.303

4.  Production of hemopoietic colony-stimulating factors by astrocytes.

Authors:  U V Malipiero; K Frei; A Fontana
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

5.  Phase I study of recombinant tumor necrosis factor in cancer patients.

Authors:  M Blick; S A Sherwin; M Rosenblum; J Gutterman
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

6.  Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

Authors:  A Fontana; H Hengartner; N de Tribolet; E Weber
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

7.  Evidence for two mechanisms by which tumor necrosis factor kills cells.

Authors:  T R Reid; F M Torti; G M Ringold
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

8.  Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines.

Authors:  T Aida; W J Bodell
Journal:  Cancer Res       Date:  1987-03-01       Impact factor: 12.701

9.  Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells.

Authors:  Y Nio; J Zighelboim; J Berek; B Bonavida
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

10.  The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies.

Authors:  J T Rutka; J R Giblin; M E Berens; E Bar-Shiva; K Tokuda; J R McCulloch; M L Rosenblum; T E Eessalu; B B Aggarwal; W J Bodell
Journal:  Int J Cancer       Date:  1988-04-15       Impact factor: 7.396

View more
  5 in total

Review 1.  Recent advances in immunobiology of brain tumors.

Authors:  M Tada; N de Tribolet
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

Review 2.  Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control.

Authors:  Russell L Blaylock
Journal:  Surg Neurol Int       Date:  2015-05-29

3.  Reciprocal Supportive Interplay between Glioblastoma and Tumor-Associated Macrophages.

Authors:  Wenchao Zhou; Shideng Bao
Journal:  Cancers (Basel)       Date:  2014-03-26       Impact factor: 6.639

4.  Adenovirus-mediated gene transduction of IkappaB or IkappaB plus Bax gene drastically enhances tumor necrosis factor (TNF)-induced apoptosis in human gliomas.

Authors:  N Shinoura; N Yamamoto; Y Yoshida; T Fujita; N Saito; A Asai; T Kirino; H Hamada
Journal:  Jpn J Cancer Res       Date:  2000-01

5.  Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis.

Authors:  Russell L Blaylock
Journal:  Surg Neurol Int       Date:  2013-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.